Search by Drug Name or NDC

    NDC 00003-1614-12 BARACLUDE 0.05 mg/mL Details

    BARACLUDE 0.05 mg/mL

    BARACLUDE is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is ENTECAVIR.

    Product Information

    NDC 00003-1614
    Product ID 0003-1614_5ea9d52c-ff85-43a8-a663-73e4f77a43d1
    Associated GPIs 12352030002020
    GCN Sequence Number 058933
    GCN Sequence Number Description entecavir SOLUTION 0.05 MG/ML ORAL
    HIC3 W5F
    HIC3 Description HEPATITIS B TREATMENT AGENTS
    GCN 24465
    HICL Sequence Number 032832
    HICL Sequence Number Description ENTECAVIR
    Brand/Generic Brand
    Proprietary Name BARACLUDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name entecavir
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 0.05
    Active Ingredient Units mg/mL
    Substance Name ENTECAVIR
    Labeler Name E.R. Squibb & Sons, L.L.C.
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021798
    Listing Certified Through 2024-12-31

    Package

    NDC 00003-1614-12 (00003161412)

    NDC Package Code 0003-1614-12
    Billing NDC 00003161412
    Package 1 BOTTLE in 1 CARTON (0003-1614-12) / 210 mL in 1 BOTTLE
    Marketing Start Date 2005-03-29
    NDC Exclude Flag N
    Pricing Information N/A